Cargando…
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity
In recent years, immunotherapy has become a powerful therapeutic option against multiple malignancies. The unique capacity of natural killer (NK) cells to attack cancer cells without antigen specificity makes them an optimal immunotherapeutic tool for targeting tumors. Several approaches are current...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562848/ https://www.ncbi.nlm.nih.gov/pubmed/36231109 http://dx.doi.org/10.3390/cells11193147 |
_version_ | 1784808266761502720 |
---|---|
author | Mendoza-Valderrey, Alberto Alvarez, Maite De Maria, Andrea Margolin, Kim Melero, Ignacio Ascierto, Maria Libera |
author_facet | Mendoza-Valderrey, Alberto Alvarez, Maite De Maria, Andrea Margolin, Kim Melero, Ignacio Ascierto, Maria Libera |
author_sort | Mendoza-Valderrey, Alberto |
collection | PubMed |
description | In recent years, immunotherapy has become a powerful therapeutic option against multiple malignancies. The unique capacity of natural killer (NK) cells to attack cancer cells without antigen specificity makes them an optimal immunotherapeutic tool for targeting tumors. Several approaches are currently being pursued to maximize the anti-tumor properties of NK cells in the clinic, including the development of NK cell expansion protocols for adoptive transfer, the establishment of a favorable microenvironment for NK cell activity, the redirection of NK cell activity against tumor cells, and the blockage of inhibitory mechanisms that constrain NK cell function. We here summarize the recent strategies in NK cell-based immunotherapies and discuss the requirement to further optimize these approaches for enhancement of the clinical outcome of NK cell-based immunotherapy targeting tumors. |
format | Online Article Text |
id | pubmed-9562848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95628482022-10-15 Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity Mendoza-Valderrey, Alberto Alvarez, Maite De Maria, Andrea Margolin, Kim Melero, Ignacio Ascierto, Maria Libera Cells Review In recent years, immunotherapy has become a powerful therapeutic option against multiple malignancies. The unique capacity of natural killer (NK) cells to attack cancer cells without antigen specificity makes them an optimal immunotherapeutic tool for targeting tumors. Several approaches are currently being pursued to maximize the anti-tumor properties of NK cells in the clinic, including the development of NK cell expansion protocols for adoptive transfer, the establishment of a favorable microenvironment for NK cell activity, the redirection of NK cell activity against tumor cells, and the blockage of inhibitory mechanisms that constrain NK cell function. We here summarize the recent strategies in NK cell-based immunotherapies and discuss the requirement to further optimize these approaches for enhancement of the clinical outcome of NK cell-based immunotherapy targeting tumors. MDPI 2022-10-06 /pmc/articles/PMC9562848/ /pubmed/36231109 http://dx.doi.org/10.3390/cells11193147 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mendoza-Valderrey, Alberto Alvarez, Maite De Maria, Andrea Margolin, Kim Melero, Ignacio Ascierto, Maria Libera Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity |
title | Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity |
title_full | Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity |
title_fullStr | Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity |
title_full_unstemmed | Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity |
title_short | Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity |
title_sort | next generation immuno-oncology strategies: unleashing nk cells activity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562848/ https://www.ncbi.nlm.nih.gov/pubmed/36231109 http://dx.doi.org/10.3390/cells11193147 |
work_keys_str_mv | AT mendozavalderreyalberto nextgenerationimmunooncologystrategiesunleashingnkcellsactivity AT alvarezmaite nextgenerationimmunooncologystrategiesunleashingnkcellsactivity AT demariaandrea nextgenerationimmunooncologystrategiesunleashingnkcellsactivity AT margolinkim nextgenerationimmunooncologystrategiesunleashingnkcellsactivity AT meleroignacio nextgenerationimmunooncologystrategiesunleashingnkcellsactivity AT asciertomarialibera nextgenerationimmunooncologystrategiesunleashingnkcellsactivity |